These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 448678)

  • 1. Actinomycin D oxazinones as improved antitumor agents.
    Sengupta SK; Trites DH; Madhavarao MS; Beltz WR
    J Med Chem; 1979 Jul; 22(7):797-802. PubMed ID: 448678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N2- and C-7 substituted actinomycin D analogues: synthesis, DNA-binding affinity, and biochemical and biological properties. Structure-activity relationship.
    Sengupta SK; Anderson JE; Kogan Y; Trites DH; Beltz WR; Madhavarao MS
    J Med Chem; 1981 Sep; 24(9):1052-9. PubMed ID: 6169834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon-7 substituted actinomycin D analogues as improved antitumor agents: synthesis and DNA-binding and biological properties.
    Sengupta SK; Anderson JE; Kelley C
    J Med Chem; 1982 Oct; 25(10):1214-9. PubMed ID: 7143358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some properties and antitumor effects of the actinomycin lactam analog, (di(1-L-alpha, beta-diaminopropionic))actinomycin D1.
    Moore S; Patel RP; Atherton E; Kondo M; Meienhofer J
    J Med Chem; 1976 Jun; 19(6):766-72. PubMed ID: 950643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracyclic chromophoric analogues of actinomycin D: synthesis, structure elucidation and interconvertibility from one form to another, antitumor activity, and structure-activity relationships.
    Sengupta SK; Madhavarao MS; Kelly C; Blondin J
    J Med Chem; 1983 Nov; 26(11):1631-7. PubMed ID: 6579306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of 2-deamino- and N2-(gamma-hydroxypropyl)actinomycin D.
    Moore S; Kondo M; Copeland M; Meienhofer J
    J Med Chem; 1975 Nov; 18(11):1098-101. PubMed ID: 809581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deaminoactinomycin D, synthesis and interaction with deoxyribonucleic acid.
    Mosher CW; Kuhlmann KF; Kleid DG; Henry DW
    J Med Chem; 1977 Aug; 20(8):1055-9. PubMed ID: 330857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of F8-actinomycin D for RNA:DNA hybrids and its anti-leukemia activity.
    Takusagawa F; Takusagawa KT; Carlson RG; Weaver RF
    Bioorg Med Chem; 1997 Jun; 5(6):1197-207. PubMed ID: 9222513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-substituted actinomycin D analogs. Chemical and growth-inhibitory studies.
    Sengupta SK; Tinter SK; Lazarus H; Brown BL; Modest EJ
    J Med Chem; 1975 Dec; 18(12):1175-80. PubMed ID: 1059773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Binding of actinomycin D analogues containing some substituents at position 7 of the antibiotic chromophore to DNA].
    Mikhaĭlov MV; Nikitin SM; Zasedatelev AC; Zhuze AL; Gurskiĭ GV; Gottikh BP
    Mol Biol (Mosk); 1979; 13(6):1322-6. PubMed ID: 547179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N7-Substituted 7-aminoactinomycin D analogues. Synthesis and biological properties.
    Madhavarao MS; Chaykovsky M; Sengupta SK
    J Med Chem; 1978 Sep; 21(9):958-61. PubMed ID: 722760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Reverse" and "symmetrical" analogues of actinomycin D: metabolic activation and in vitro and in vivo tumor growth inhibitory activities.
    Sengupta SK; Kelly C; Sehgal RK
    J Med Chem; 1985 May; 28(5):620-8. PubMed ID: 2985784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomers of 7-(2,3-epoxypropoxy)actinomycin D as dual-action DNA-acting antitumor agents.
    Sengupta SK; Rosenbaum DP; Sehgal RK; Almassian B; Blondin J
    J Med Chem; 1988 Aug; 31(8):1540-7. PubMed ID: 3397991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New actinomycin D analogues as superior chemotherapeutic agents against primary and advanced colon tumors and colon xenografts in nude mice.
    Sengupta SK; Kogan Y; Kelly C; Szabo J
    J Med Chem; 1988 Apr; 31(4):768-74. PubMed ID: 3351854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and properties of some peptide analogues of actinomycin D.
    Mauger AB; Stuart OA; Katz E
    J Med Chem; 1991 Apr; 34(4):1297-301. PubMed ID: 1707976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 May; 62(5):779-89. PubMed ID: 77730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides.
    Zhang BZ; Wang KR; Yan JX; Zhang W; Song JJ; Ni JM; Wang R
    Peptides; 2010 Apr; 31(4):568-73. PubMed ID: 20045716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of bis-dipeptide and bis-tripeptide analogues of actinomycin D.
    Azad Chowdhury AK; Brown JR; Longmore RB
    J Med Chem; 1978 Jul; 21(7):607-12. PubMed ID: 97381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological properties of N2-substituted spin-labeled analogues of actinomycin D.
    Sinha BK; Cox MG; Chignell CF; Cysyk RL
    J Med Chem; 1979 Sep; 22(9):1051-5. PubMed ID: 226705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
    J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.